In this week’s Crypto Long & Short Newsletter, Abdul Rafay Gadit writes about how DATCO’s are reshaping corporate finance.

Nektar Therapeutics develops novel immunomodulatory drugs targeting autoimmune diseases and oncology. Click here to read why ...

Good morning, everyone, and welcome, everyone, to the Prelude Therapeutics Investor Conference Call. Today's call is being recorded and is expected to last up to 45 minutes. At this time, I will now ...

Q3 2025 Earnings Call Transcript November 10, 2025 AST SpaceMobile, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Discover the best home-improvement products—lab-tested, expert-approved upgrades for kitchens, baths, and beyond from Good ...

Exercise equipment, gym accessories, workout tech and more - we rounded up the best fitness gifts for treating someone who ...

One of America's top-selling EVs struggles in Australia, but the 2026 Ford Mustang Mach-E facelift ushers in welcome changes, including improved suspension, more range and better value. Plus, as the ...

Presented robust CRB-701 clinical data at ESMO 2025 - 3.6 mg/kg dose generated ORR of 47.6% in HNSCC, 37.5% in cervical cancer and 55.6% in mUCCRB-701 HNSCC registrational study planned to start ...